Alunbrig

Alunbrig (Brigatinib) is an oral medication used to treat certain types of cancer. Learn about its uses, effects, and precautions here.

Alunbrig is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. It is often prescribed for patients who have specific genetic mutations, such as those with ALK-positive NSCLC. The medication works by targeting and inhibiting certain proteins that contribute to the growth and spread of cancer cells. Patients and healthcare providers should discuss the specific uses of Alunbrig and whether it is suitable for their condition.

Common effects of Alunbrig may include nausea, fatigue, and diarrhea. Some patients may also experience cough, increased blood pressure, and muscle pain. These effects can vary in severity and duration. It is important to monitor any side effects and consult a healthcare provider if they become severe or persistent.

Alunbrig should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Alunbrig may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. This can affect the effectiveness of Alunbrig or other medications. Patients should avoid grapefruit and grapefruit juice, as they can also interact with Alunbrig. It is important to discuss all current medications with a healthcare provider to minimize the risk of interactions.